Karen L. Zaderej
Karen L. Zaderej's purchase track record
Karen L. Zaderej has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/18/2026 | EYPT | $52K | pending | pending | — |
| 5/14/2025 | EYPT | $113K | +100.6% | +118.4% | +16.3% |
| 8/19/2024 | EYPT | $100K | +8.1% | -17.6% | +9.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Axogen Receives New Analyst Coverage and Valuation Upside. Axogen has attracted new analyst coverage from Robinhood and B of A Securities, both issuing bullish notes and setting price targets around $52. A Yahoo analysis suggests the stock may be about 26% undervalued on cash‑flow grounds, while the company has fallen 22.6% in the past month. These developments highlight renewed investor interest and potential upside relative to recent price action.
Transaction History
| EYPT | ▲ Buy | Open Market | 10,600 | $52K | 8/18/2026 | View on chart |
| EYPT | ▲ Buy | Option Exercise | 2,000 | $0 | 7/11/2025 | View on chart |
| EYPT | ▲ Buy | Open Market | 5,000 | $30K | 5/19/2025 | View on chart |
| EYPT | ▲ Buy | Open Market | 5,000 | $29K | 5/16/2025 | View on chart |
| EYPT | ▲ Buy | Open Market | 5,000 | $27K | 5/15/2025 | View on chart |
| EYPT | ▲ Buy | Open Market | 5,000 | $27K | 5/14/2025 | View on chart |
| EYPT | ▲ Buy | Open Market | 12,500 | $100K | 8/19/2024 | View on chart |
| EYPT | ▲ Buy | Option Exercise | 2,000 | $0 | 7/11/2024 | View on chart |
| AXGN | ▼ Sell | Open Market | 33,028 | $254K | 3/21/2024 | View on chart |
| AXGN | ▼ Sell | Open Market | 3,166 | $24K | 3/21/2024 | View on chart |
| AXGN | ▼ Sell | Open Market | 3,086 | $24K | 3/21/2024 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 84,847 | $0 | 3/16/2024 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 12,500 | $0 | 3/16/2024 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 12,975 | $0 | 3/16/2024 | View on chart |
| AXGN | ▲ Buy | Grant | 22,076 | $0 | 7/18/2023 | View on chart |
| EYPT | ▲ Buy | Option Exercise | 2,000 | $0 | 7/11/2023 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 25,000 | $0 | 3/16/2023 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 12,975 | $0 | 3/16/2023 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 4,400 | $0 | 12/27/2022 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 26,746 | $136K | 12/15/2022 | View on chart |
| AXGN | ▼ Sell | Other | 9,081 | $76K | 7/19/2022 | View on chart |
| AXGN | ▲ Buy | Grant | 22,076 | $0 | 7/18/2022 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 25,950 | $0 | 3/16/2022 | View on chart |
| AXGN | ▲ Buy | Grant | 13,978 | $0 | 2/15/2022 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 4,400 | $0 | 12/27/2021 | View on chart |
| AXGN | ▼ Sell | Tax Withholding | 1,752 | $17K | 12/27/2021 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 3,125 | $0 | 12/20/2021 | View on chart |
| AXGN | ▼ Sell | Tax Withholding | 1,243 | $11K | 12/20/2021 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 52,375 | $469K | 11/24/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Yahoo article highlights EYPT as a potential portfolio addition
A recent Yahoo article discussed EyePoint Inc. (EYPT) and listed reasons why the stock could be considered for a portfolio. The piece referenced the company's analyst consensus target of $25.91 and its 52‑week range of $2.93 to $19.11. The article’s positive tone adds to current market conversation around the stock.
Yahoo article highlights EYPT as a potential portfolio addition. A recent Yahoo article discussed EyePoint Inc. (EYPT) and listed reasons why the stock could be considered for a portfolio. The piece referenced the company's analyst consensus target of $25.91 and its 52‑week range of $2.93 to $19.11. The article’s positive tone adds to current market conversation around the stock.